Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HER2-ultralow status in HR-positive, HER2-negative ...
HØST PtX Esbjerg, developed by CIP, celebrates the Danish government’s recent announcement about the planned hydrogen pipeline between Denmark and Germany, set for completion in 2030. This milestone ...